title: [Combined treatment for rectal cancer using different radiomodification means].
abstract: The paper presents an evaluation of the results of surgical and combined treatment received by 961 patients at the Center's Clinics within 28 years. The analysis was based on 3 protocols of prospective randomized study. It dealt with assessment of the end results of surgical and combined treatment for operable rectal cancer using one preoperative hyperfractonated STD of 5-25 Gy. That was combined with local microwave hyperthermia and two radio modifiers--local microwave hyperthermia+intrarectal administration of a preparation containing metronidazolum. Due to the latter factor, the rate of 3-year relapse-free survival rose considerably. Also, loco-regional and distant metastasis incidence was cut down due to superior ablasticity of surgery.
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Barsukov
authors.forename: S I
authors.initials: SI
authors.lastname: Tkachev
authors.forename: N D
authors.initials: ND
authors.lastname: Oltarzhevskaia
authors.forename: M A
authors.initials: MA
authors.lastname: Korovina
authors.forename: S P
authors.initials: SP
authors.lastname: Iarmolenko
authors.forename: A A
authors.initials: AA
authors.lastname: Vaĭnson
authors.forename: A G
authors.initials: AG
authors.lastname: Perevoshchikov
authors.forename: A V
authors.initials: AV
authors.lastname: Nikolaev
authors.forename: A T
authors.initials: AT
authors.lastname: Gradiushko
authors.forename: T O
authors.initials: TO
authors.lastname: Kutateladze
authors.forename: O A
authors.initials: OA
authors.lastname: Vlasov
authors.forename: A G
authors.initials: AG
authors.lastname: Malikho
authors.forename: R I
authors.initials: RI
authors.lastname: Tamrazov
authors.forename: D V
authors.initials: DV
authors.lastname: Kuz'michev
authors.forename: V A
authors.initials: VA
authors.lastname: Aliev
authors.forename: Z Z
authors.initials: ZZ
authors.lastname: Mamedli
mesh_terms: D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012004:Rectal Neoplasms / Q000401:mortality* / Q000628:therapy*; D012189:Retrospective Studies; D015996:Survival Rate